ETHOTOIN |
PEGANONE |
ETHOTOÏNE |
3-ETHYL-5-PHENYL-IMIDAZOLIDINE-2,4-DIONE |
3-ETHYL-5-PHENYLIMIDAZOLIDIN-2,4-DIONE |
ETHOTOINUM |
3-ETHYL-5-PHENYLHYDANTOIN |
1-ETHYL-2,5-DIOXO-4-PHENYLIMIDAZOLIDINE |
ETOTOINA |
PEGANONE® |
3-ETHYL-5-PHENYL-2,4-IMIDAZOLIDINEDIONE |
(+-)-3-ETHYL-5-PHENYLHYDANTOIN |
chembl:CHEMBL1095 |
pubchem.compound:3292 |
drugbank:00754 |
rxcui:4136 |
chemidplus:86-35-1 |
Drug Class | anticonvulsants |
Year of Approval | 1957 |
FDA Approval | 1957 |
Drug Class | small molecule |
Drug Indications | Anticonvulsants |
blocker (inhibitory) |
inhibitor (inhibitory) |
Trial Name | - |
Novel drug target | Established target |
Mechanism of Interaction | Sodium channel alpha subunit blocker |
blocker (inhibitory) |
Mechanism of Interaction | Sodium channel alpha subunit blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Sodium channel alpha subunit blocker |
blocker (inhibitory) |
Mechanism of Interaction | Sodium channel alpha subunit blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Mechanism of Interaction | Sodium channel alpha subunit blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Mechanism of Interaction | Sodium channel alpha subunit blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Mechanism of Interaction | Sodium channel alpha subunit blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Mechanism of Interaction | Sodium channel alpha subunit blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Mechanism of Interaction | Sodium channel alpha subunit blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Sodium channel alpha subunit blocker |
ETHOTOIN | Primary Drug Name |
Year of Approval | 1957 |
Drug Class | anticonvulsants |
Drug Indications | Anticonvulsants |
Drug Class | small molecule |
FDA Approval | 1957 |
D05EPM | TTD Drug ID |